Skip to main content

Advertisement

SpringerLink
Log in

Management of the axilla in patients with breast cancer

  • Review Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

This article reviews the changes in management of the axilla in patients with breast cancer in the last decade. It discusses the recent advances, existing controversies and provides evidence-based guidelines for use in clinical practice.

Sentinel lymph node (SLN) biopsy has replaced the more morbid axillary lymph node dissection (ALND) and four node sampling for axillary nodal staging. Blue dye guided four node sampling is an acceptable alternative when radioisotope facilities are not available. ALND is reserved for patients with proven axillary lymph node involvement.

Preoperative axillary ultrasound and fine-needle aspiration cytology or core biopsy of suspicious lymph nodes reliably identifies around 30% of node positive patients. Intraoperative assessment of the SLN using frozen section or real time molecular assays enables surgeons to perform one stage ALND in node positive patients. For those patients in whom intra-operative SLN assessment is negative, but whose final pathology reveals SLN metastasis, standard treatment has been to perform a completion ALND. Predictive models can be used to identify a lowrisk group of SLN-positive patients in whom routine ALND may not be necessary. In the future, completion ALND for microscopic disease will not be the standard of care but axillary radiotherapy may be an alternative with equal control and less morbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mansel RE, et al. (2006) Randomised multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609

    Article  PubMed  Google Scholar 

  2. Fisher B, et al. (2002) Twenty-five-year follow-up of a randomised trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347:567–575

    Article  PubMed  Google Scholar 

  3. Clarke M, et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106

    CAS  PubMed  Google Scholar 

  4. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer—results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203–208

    Article  PubMed  Google Scholar 

  5. Goyal A, et al. Results of the UK NEW START sentinel node biopsy training program: a model for future surgical training. Proceedings of 32nd annual San Antonio Breast Cancer Symposium 2009.

  6. http://www.nice.org.uk/Guidance/CG80. Accessibility checked on 28/02/09 2009.

  7. Goyal A, et al. (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ? Analysis of 587 cases. Breast Cancer Res Treat 98:311–314

    Article  PubMed  Google Scholar 

  8. Povoski SP, et al. (2006) Prospective randomised clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 13:1412–1421

    Article  PubMed  Google Scholar 

  9. McMasters KM, et al. (2001) Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233:676–687

    Article  CAS  PubMed  Google Scholar 

  10. Klimberg VS, et al. (1999) Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 229:860–864

    Article  CAS  PubMed  Google Scholar 

  11. Mansel RE, Goyal A, Newcombe RG (2004) Internal mammary node drainage and its role in sentinel lymph node biopsy: the initial ALMANAC experience. Clin Breast Cancer 5:279–284

    Article  PubMed  Google Scholar 

  12. Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE (2009) Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience. Eur J Surg Oncol (In press)

  13. Goyal A, et al. (2005) Role of routine preoperative lymphoscintigraphy in sentinel node biopsy for breast cancer. Eur J Cancer 41:238–243

    Article  PubMed  Google Scholar 

  14. Port ER, et al. (2002) Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195:167–172

    Article  PubMed  Google Scholar 

  15. Port ER, et al. (2007) Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14:2209–2214

    Article  PubMed  Google Scholar 

  16. Intra M, et al. (2007) Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 94:1216–1219

    Article  CAS  PubMed  Google Scholar 

  17. Tew K, Irwig L, Matthews A, Crowe P, Macaskill P (2005) Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92:1068–1080

    Article  CAS  PubMed  Google Scholar 

  18. Johnston EI, Beach RA, Waldrop SM, Lawson D, Cohen C (2006) Rapid intraoperative immunohistochemical evaluation of sentinel lymph nodes for metastatic breast carcinoma. Appl Immunohistochem Mol Morphol 14:57–62

    Article  PubMed  Google Scholar 

  19. Viale G, et al. (1999) Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85: 2433–2438

    Article  CAS  PubMed  Google Scholar 

  20. Viale G, et al. (2008) Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 247:136–142

    Article  PubMed  Google Scholar 

  21. Blumencranz P, et al. (2007) Scientific Impact Recognition Award. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 194:426–432

    Article  PubMed  Google Scholar 

  22. Mansel RE, et al. (2008) Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearchtrade mark BLN Assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat

  23. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE (2004) Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 40:1731–1737

    Article  CAS  PubMed  Google Scholar 

  24. Park J, et al. (2007) A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462–468

    Article  PubMed  Google Scholar 

  25. Mansel RE, Goyal A (2004) European studies on breast lymphatic mapping. Semin Oncol 31:304–310

    Article  PubMed  Google Scholar 

  26. Baruah B, Goyal A, Young P, Douglas-Jones A, Mansel R (2009) Axillary nodal staging by ultrasonography and fineneedle aspiration cytology in patients with breast cancer. Br J Surg (in press)

  27. Goyal A, et al. (2004) Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 30:475–479

    Article  CAS  PubMed  Google Scholar 

  28. Schrenk P, Wayand W (2001) Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 357:122

    Article  CAS  PubMed  Google Scholar 

  29. Knauer M, et al. (2006) Multicentric breast cancer: a new indication for sentinel node biopsy—a multi-institutional validation study. J Clin Oncol 24:3374–3380

    Article  PubMed  Google Scholar 

  30. Xing Y, et al. (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539–546

    Article  CAS  PubMed  Google Scholar 

  31. Taback B, et al. (2006) Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13:1099–1104

    Article  PubMed  Google Scholar 

  32. Cox CE, et al. (2008) Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg 207:57–61

    Article  PubMed  Google Scholar 

  33. Goyal A, Newcombe RG, Mansel RE (2005) Clinical relevance of multiple sentinel nodes in patients with breast cancer. Br J Surg 92:438–442

    Article  CAS  PubMed  Google Scholar 

  34. Purushotham AD, et al. (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomised controlled trial. J Clin Oncol 23:4312–4321

    Article  PubMed  Google Scholar 

  35. Veronesi U, et al. (2003) A randomised comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553

    Article  PubMed  Google Scholar 

  36. Zavagno G, et al. (2008) A Randomised clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207–213

    Article  PubMed  Google Scholar 

  37. van der Ploeg IM, Nieweg OE, van Rijk MC, Valdés Olmos RA, Kroon BB. (2008) Axillary recurrence after a tumournegative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature. Eur J Surg Oncol 34(12):1277–1284

    PubMed  Google Scholar 

  38. Forrest AP, et al. (1995) The Edinburgh randomised trial of axillary sampling or clearance after mastectomy. Br J Surg 82:1504–1508

    Article  CAS  PubMed  Google Scholar 

  39. Chetty U, Jack W, Prescott RJ, Tyler C, Rodger A (2000) Management of the axilla in operable breast cancer treated by breast conservation: a randomised clinical trial. Edinburgh Breast Unit. Br J Surg 87:163–169

    Article  CAS  PubMed  Google Scholar 

  40. Monypenny IJ, Dixon M, Kissin M, Newcombe RG, Goyal A, Mansel RE. (2005) End of 4 node sampling?- Comparative morbidity versus sentinel lymph node biopsy in the ALMANAC trial. Proceedings of the Nottingham Breast Cancer Conference 2005.

  41. Chetty U, Chin PK, Soon PH, Jack W, Thomas JS (2008) Combination blue dye sentinel lymph node biopsy and axillary node sampling: the Edinburgh experience. Eur J Surg Oncol 34:13–16

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, School of Medicine, Cardiff University, Cardiff, CF14 4XN, UK

    Amit Goyal

Authors
  1. Amit Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit Goyal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goyal, A. Management of the axilla in patients with breast cancer. Indian J Surg 71, 328–334 (2009). https://doi.org/10.1007/s12262-009-0089-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-009-0089-1

Keywords

Search

Navigation